Tumors
Finding Tissue Abnormalities
Is it benign or malignant? Two words that carry a huge amount of emotional weight for patients, of course, and for the doctors caring for those patients. So what if finding tissue abnormalities was less invasive, less expensive, and offered fewer false-positives and more reliable results? Canary's work on tumors across a range of cancer types focuses on earlier detection and the use of advanced technologies to better image tumor formation and distinguish cancer from benign disease.
Multidisciplinary Cancer Research
The Canary Foundation's tumor research programs bring together multidisciplinary teams of scientists, engineers, and clinicians focused on developing early detection methods for the deadliest cancers. Each program combines biomarker discovery, advanced imaging, and population studies to create comprehensive detection strategies.
Built on Sanjiv Sam Gambhir's early-detection vision, our current scientific teams are making significant advances in detecting cancer at its earliest, most treatable stages. From the PASS study in prostate cancer to microbubble technology for pancreatic cancer, our research is transforming cancer detection.
Our Cancer Research Programs
Lung Cancer
Special focus on never-smokers and underserved communities with innovative screening approaches.
Learn MoreOvarian Cancer
Pioneering HE4 biomarker validation and prevention strategies for the "silent killer."
Learn MorePancreatic Cancer
Revolutionary microbubble ultrasound technology detecting tumors smaller than 1mm.
Learn MoreProstate Cancer
Leading PASS study with 2,400+ participants shaping national screening guidelines.
Learn MoreIntegrated Research Approach
All our tumor research programs share common methodologies and collaborate to accelerate discovery:
Biomarker Discovery
- Blood-based detection methods
- Circulating tumor DNA analysis
- Protein and metabolic markers
Advanced Technologies
- AI-enhanced imaging analysis
- Molecular imaging techniques
- Point-of-care diagnostics
Collective Impact
World-Class Leadership
Our tumor research programs are led by internationally recognized experts in cancer biology, molecular imaging, and clinical research. Sanjiv Sam Gambhir's vision of detecting cancer at the cellular level continues to guide our work.
Each program benefits from collaboration with leading cancer centers including Stanford, Fred Hutchinson, MD Anderson, and the National Cancer Institute, ensuring our research translates rapidly into clinical practice.
Support Cancer Research
Your support helps advance early detection research across Canary's active cancer programs, bringing us closer to a world where cancer is detected and treated before symptoms appear.